Zogenix CEO Goes on the Offensive
Zogenix has traded like a company that is about to implode. Its highly controversial Zohydro has been getting inquiries into how it was approved for marketing despite an FDA panel being against the recommendation.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 293Biopharma Firm Versartis Gets Golden IPO Treatment
Biopharmaceutical firm Versartis sold 6 million shares in a Friday morning IPO at a price higher than the estimated range. Shares were up more than 60% in the noon hour.
Did Endocyte Just Become Buyout Bait?
Endocyte is trading like it is being acquired. This is proof that any biotech with great cancer drug news can run, regardless of market conditions. One has to wonder if Endocyte is among the…
Could Obamacare Be Working?
WellPoint raised its earnings outlook for the 2014 fiscal year, citing a benefit from the Affordable Care Act, aka Obamacare, and the expected addition of a million or more new members.
Akebia, MediWound Post Gains Following IPOs
Mediwound offered 5 million shares in a Thursday IPO at the low end of the expected range. Akebia Therapeutics offered 5.9 million shares in its IPO at the high end of the expected price…
Are Biotech Stocks Located in Ireland Top Buyout Candidates?
St. Patrick's Day may have come and gone for this year, but the analysts at biotech boutique shop Leerink have highlighted six Ireland-based firms that could be tempting takeover targets for large biotech and…
Castlight Health IPO: The Cloud’s the Limit
Health care software maker Castlight Health launched its initial public offering (IPO) Friday morning, and "launch" is the right word. Shares have taken off, rising more than 162% in early trading.
Why Teva May Be Back From the Dead
Two analyst upgrades on Friday, a new CEO and a 33% increase in its stock price since November may be confirmation that Teva Pharmaceutical Industries is finally rebounding. Analysts think the stock could move…
Ten Top Biotech Merger and Partnership Candidates
In a new research report, the boutique firm Leerink highlights 10 top biotech names that are strong candidates for a partnership or acquisition. Any of these picks may be a great addition for portfolios…
Jefferies’ Cheapest Health Care Stocks to Buy
In a new report out from Jefferies, the analysts posted a complete list of the cheapest, on a P/E basis, of the top health care stocks to buy now. Investors concerned about the toppy…
Smoking Rate Highest in Kentucky, Lowest in Utah
courtesy of NBN at German WikipediaMore than 30.2% of people in Kentucky were smokers in 2013. Barely behind at 29.9% were the residents of adjacent West Virginia. At the other end of the spectrum,…
Pfizer Will Appeal Court Decision Regarding Celebrex Reissue Patent
Wikimedia CommonsShares of drug maker Pfizer Inc. (NYSE: PFE) were halted Wednesday afternoon at $32.29, down about 0.4% from the opening price. The company announced that its patent infringement case against a number of…
Zogenix Tumbles on Fears Its Pain Drug May Lose Out to a Rival
Shares of Zogenix fell as much as 26% on Wednesday after a rival pharmaceutical company said it will seek regulatory approval of a tamper-proof version of Zogenix's powerful new pain drug.
Back to Normalcy at Geron
Geron is getting a reality check on Wednesday. After a recovery from years of disappointment, this is starting to feel again like the Geron that everyone knew before.
Short Sellers Retreat From Biotech Stocks Again
Biotech and emerging pharmaceutical stocks continue to be hot, but short sellers shied away from many of them in late February. Those bucking that trend include BioMarin Pharmaceutical and Medivation.